GenomeDx closes series A round

Molecular diagnostics company GenomeDx Biosciences Inc. (Vancouver, B.C.) raised an undisclosed amount in a series A round led by new investors Baird Venture Partners and Aeris Capital. New investor CD Ventures and a group of new and existing individual investors also participated. Baird's Mike Liang and Aeris' George Rehm joined GenomeDx's board. ...